Véronique Gobry Patient Spouse

Véronique’s husband Fred was diagnosed with Multiple Myeloma 6 years ago. With Fred and their daughter they hiked the Grand Canyon with the MM4MM team in 2015. Since then she has ran several half-marathons with Team for cure. 

She is pretty new to cycling but it is a challenge she feels strongly about because even with the amazing advances in the treatments raising money for research remains a priority.

R2V gives me something I can do to help and support my husband…
Veronique Gobry
Only three short days before the start of the R2V Vermont to Quebec Ride, an event I am very grateful for having the opportunity to be part of.  My husband…
Read More
09/14/2019
The mission of the Multiple Myeloma Research Foundation (MMRF) is to find a cure for multiple myeloma by relentlessly pursuing innovation that accelerates the development of next-generation treatments to extend the lives of patients. Founded in 1998 by Kathy Giusti, a multiple myeloma patient, and her twin sister Karen Andrews as a 501(c) (3) nonprofit organization, the MMRF is a world-recognized leader in cancer research. Together with its partners, the MMRF has created the only end-to-end solution in precision medicine and the single largest genomic dataset in all cancers. The MMRF continues to disrupt the industry today, as a pioneer and leader at the helm of new research efforts. Since its inception, the organization has raised over $400 million and directs nearly 90% of the total funds to research and related programs. Learn more and sign up to receive news and resources from the MMRF.

Learn More

At Janssen Oncology, we’re shaping the future of cancer treatment. In the process, we’re striving to change expectations of what a cancer diagnosis means. Our purpose is driven by an urgency and commitment to bringing transformational cancer solutions to the people who need them. Passionate about our work, we are driven by the personal connection many of us share with the disease. With our partners, we focus on delivering solutions that make a positive impact on human health. We are part of Janssen Biotech, Inc., and the Janssen Pharmaceutical Companies of Johnson & Johnson.

About Janssen Oncology

Click below to learn more about a treatment option for multiple myeloma. If you’re also interested in getting more information from Janssen, sign up for ongoing communications.

Learn More